Skip to main content
SCYNEXIS INC logo

SCYNEXIS INC — Investor Relations & Filings

Ticker · SCYX ISIN · US8112922005 LEI · 529900XBHFGMNTU70154 US Manufacturing
Filings indexed 684 across all filing types
Latest filing 2015-09-18 Director's Dealing
Country US United States of America
Listing US SCYX

About SCYNEXIS INC

https://www.scynexis.com/

SCYNEXIS, Inc. is a biotechnology company focused on the discovery and development of novel anti-infectives to overcome difficult-to-treat and drug-resistant fungal infections. The company is pioneering a new class of broad-spectrum antifungal agents called 'fungerps,' which are triterpenoid-based compounds. These agents are being developed in both oral and intravenous formulations to treat a range of serious, invasive, and life-threatening fungal diseases, particularly those encountered in hospital environments. SCYNEXIS aims to address the significant global health threat of antifungal resistance by providing innovative therapeutic options where existing treatments are limited or ineffective. The company's development pipeline includes second-generation fungerp candidates.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2015-09-18 English
FORM 4
Director's Dealing
2015-09-02 English
FORM 4
Director's Dealing
2015-08-31 English
FORM 4
Director's Dealing
2015-08-27 English
10-Q
Interim / Quarterly Report Q2 2015
2015-08-19 English
NOTIFICATION OF LATE FILING
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 filed with the SEC, titled 'Notification of Late Filing.' It specifically states that the company, SCYNEXIS, Inc., was unable to file its Form 10-Q quarterly report for the period ended June 30, 2015, on time and provides detailed reasons for the delay. The document does not contain the actual financial statements or substantive financial data of the 10-Q report but is a notification explaining the delay and the expected filing date. According to the classification rules, such a notification is a regulatory filing and not the actual interim/quarterly report itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2015-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.